Table of Contents
1. Introduction
1.1 Definition
1.2 scope of study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3. Market dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4. Market factor analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Vesicoureteral reflux market, by Types
5.1 Primary Vesicoureteral Reflux
5.2 Secondary Vesicoureteral Reflux
6. Global Vesicoureteral reflux market, By Diagnosis
6.1 Introduction
6.2 Cystography
6.3 Voiding Cystourethrogram (VCUG)
6.4 Ultrasound
6.5 Scintigraphy
6.6 Urinalysis
6.7 Others
7. Global Vesicoureteral reflux market, by Drug Treatment
7.1 Introduction
7.2 Quinolones
7.3 Aminoglycosides
7.4 Î’-Lactam
7.5 Azoles
7.6 Others
8. Global Vesicoureteral reflux market, by Surgery (
8.1 Introduction
8.2 Open Surgery
8.3 Robotic-Assisted Laparoscopic Surgery
8.4 Endoscopic Surgery
8.5 Others
9. Global Vesicoureteral reflux market, By End Users
9.1 Hospitals And Clinics
9.2 Academics And Research
9.3 Others
10. Global Vesicoureteral reflux market, By Region
10.1 North America
10.1.1 Introduction
10.2 Europe
10.2.1 Introduction
10.3 Asia-Pacific
10.3.1 Introduction
10.4 Middle East & Africa
10.4.1 Introduction
11. Competitive landscape
11.1 Major Strategies Adopted By Market Players
11.1.1 Strategic Partnership
11.1.2 Merger & Acquisition
12. Company profile
12.1 Salix Pharmaceuticals
12.1.1 Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 Key Developments
12.2 Q-Med Scandinavia Inc.
12.2.1 Overview
12.2.2 Product Overview
12.2.3 Financials
12.2.4 Key Developments
12.3 Cook Medical
12.3.1 Overview
12.3.2 Product Overview
12.3.3 Financials
12.3.4 Key Development
12.4 Salix Pharmaceuticals, Ltd.,
12.4.1 Overview
12.4.2 Product Overview
12.4.3 Financials
12.4.4 Key Developments
12.5 Bayer AG
12.5.1 Overview
12.5.2 Product Overview
12.5.3 Financials
12.5.4 Key Developments
12.6 Novartis AG
12.6.1 Overview
12.6.2 Product Overview
12.6.3 Financials
12.6.4 Key Developments
12.7 Pfizer Inc.
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Developments
12.9 Others
13. Conclusion
13.1 Key Findings
13.1.1 From Ceo’s Viewpoint
13.1.2 Unmet Needs Of The Market
13.2 Key Companies To Watch
13.3 Prediction Of Vesicoureteral Reflux Diagnosis And Treatment Industry
14. Appendix
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
